Aquestive Therapeutics Inc
NASDAQ:AQST
Aquestive Therapeutics Inc
Total Current Assets
Aquestive Therapeutics Inc
Total Current Assets Peer Comparison
Competitive Total Current Assets Analysis
Latest Figures & CAGR of Competitors
Company | Total Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
A
|
Aquestive Therapeutics Inc
NASDAQ:AQST
|
Total Current Assets
$113.4m
|
CAGR 3-Years
37%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
Johnson & Johnson
NYSE:JNJ
|
Total Current Assets
$57B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
0%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Total Current Assets
$28.7B
|
CAGR 3-Years
2%
|
CAGR 5-Years
11%
|
CAGR 10-Years
7%
|
|
Pfizer Inc
NYSE:PFE
|
Total Current Assets
$42.4B
|
CAGR 3-Years
2%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-3%
|
|
Merck & Co Inc
NYSE:MRK
|
Total Current Assets
$31.4B
|
CAGR 3-Years
5%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-3%
|
|
Eli Lilly and Co
NYSE:LLY
|
Total Current Assets
$25.2B
|
CAGR 3-Years
15%
|
CAGR 5-Years
15%
|
CAGR 10-Years
7%
|
See Also
What is Aquestive Therapeutics Inc's Total Current Assets?
Total Current Assets
113.4m
USD
Based on the financial report for Mar 31, 2024, Aquestive Therapeutics Inc's Total Current Assets amounts to 113.4m USD.
What is Aquestive Therapeutics Inc's Total Current Assets growth rate?
Total Current Assets CAGR 5Y
15%
Over the last year, the Total Current Assets growth was 159%. The average annual Total Current Assets growth rates for Aquestive Therapeutics Inc have been 37% over the past three years , 15% over the past five years .